Rapid Response® Drugs of Abuse Tests
Rapid Response® Drugs of Abuse Tests
Toronto, Canada â BTNX Inc. has launched a series of Rapid Response® advanced FDA approved in-vitro diagnostic drugs of abuse tests, which are used for home, professional and corporation point of care drugs of abuse testing.
The drug tests can easily detect any of Amphetamine, Barbiturate, Benzodiazepine, Buprenorphine, Cocaine, Ecstasy, EDDP (Methadone Metabolite), Heroin, Marijuana, Methadone, Methamphetamine, Morphine, Opiate, Â Â Oxycodone, Phencyclidine, Â Propoxyphene, Tricyclic Antidepressant. Or any combinations range from 1 test panel to 12 test panels.
Rapid Response ® drugs of abuse  test series includes urine drug test cups, urine drug test panels, urine drug test strips, urine drug test cassettes, saliva drug tests and lab hair drug tests.
Rapid Response® branded are trusted by professionals in laboratories, physiciansâ offices, hospitals and clinics worldwide for their diagnostic testing requirements.
For more information about the products please visit http://www.BTNX.com , or contact [email protected].
Toronto, Canada â BTNX Inc. has launched a series of Rapid Response® advanced FDA approved in-vitro diagnostic drugs of abuse tests, which are used for home, professional and corporation point of care drugs of abuse testing.
The drug tests can easily detect any of Amphetamine, Barbiturate, Benzodiazepine, Buprenorphine, Cocaine, Ecstasy, EDDP (Methadone Metabolite), Heroin, Marijuana, Methadone, Methamphetamine, Morphine, Opiate, Â Â Oxycodone, Phencyclidine, Â Propoxyphene, Tricyclic Antidepressant. Or any combinations range from 1 test panel to 12 test panels.
Rapid Response ® drugs of abuse  test series includes urine drug test cups, urine drug test panels, urine drug test strips, urine drug test cassettes, saliva drug tests and lab hair drug tests.
Rapid Response® branded are trusted by professionals in laboratories, physiciansâ offices, hospitals and clinics worldwide for their diagnostic testing requirements.
BTNX Inc. is a biotechnology company and a world leader in rapid, point-of-care diagnostics. BTNX Inc. specializes in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests and information technology systems to manage point-of-care diagnostic test results using HL7/POCT1-A2 compliant software solutions for laboratories, clinics, hospitals and physiciansâ offices.